Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marzia Del Re

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
Diagnostics (Basel, Switzerland)|June 24, 2022
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular ToolSara Galimberti, Serena Balducci, Francesca Guerrini, et al.
Pharmacogenomics|June 9, 2017
Should CYP2D6 be genotyped when treating with tamoxifen?Marzia Del Re, Eleonora Rofi, Valentina Citi, et al.
Pharmacological Research|March 8, 2021
Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practiceStefano Fogli, Sara Galimberti, Veronica Gori, et al.
Pharmacogenomics|November 25, 2016
Should CYP2D6 be genotyped when treating with tamoxifen?Marzia Del Re, Eleonora Rofi, Valentina Citi, et al.
Expert Review of Molecular Diagnostics|April 15, 2014
Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancerMarzia Del Re, Enrico Vasile, Alfredo Falcone, et al.
Pharmacological Research|November 27, 2015
Pathophysiology and pharmacological targets of VEGF in diabetic macular edemaStefano Fogli, Selene Mogavero, Colin Gerard Egan, et al.
Epigenomics|August 2, 2016
Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implicationsAntonello Di Paolo, Marzia Del Re, Iacopo Petrini, et al.
Eye (London, England)|February 6, 2018
Clinical pharmacology of intravitreal anti-VEGF drugsStefano Fogli, Marzia Del Re, Eleonora Rofi, et al.
Cancer Treatment Reviews|April 30, 2026
Streptozotocin revisited: Pharmacological determinants supporting new scheduling strategies in neuroendocrine tumoursNicola Fazio, Francesca Spada, Lavinia Benini, et al.
Journal of Theoretical Biology|November 10, 2015
Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancerSheema Sameen, Roberto Barbuti, Paolo Milazzo, et al.
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Diagnostics (Basel, Switzerland)|June 24, 2022
Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular ToolSara Galimberti, Serena Balducci, Francesca Guerrini, et al.
Pharmacogenomics|June 9, 2017
Should CYP2D6 be genotyped when treating with tamoxifen?Marzia Del Re, Eleonora Rofi, Valentina Citi, et al.
Pharmacological Research|March 8, 2021
Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practiceStefano Fogli, Sara Galimberti, Veronica Gori, et al.
Pharmacogenomics|November 25, 2016
Should CYP2D6 be genotyped when treating with tamoxifen?Marzia Del Re, Eleonora Rofi, Valentina Citi, et al.
Expert Review of Molecular Diagnostics|April 15, 2014
Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancerMarzia Del Re, Enrico Vasile, Alfredo Falcone, et al.
Pharmacological Research|November 27, 2015
Pathophysiology and pharmacological targets of VEGF in diabetic macular edemaStefano Fogli, Selene Mogavero, Colin Gerard Egan, et al.
Epigenomics|August 2, 2016
Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implicationsAntonello Di Paolo, Marzia Del Re, Iacopo Petrini, et al.
Eye (London, England)|February 6, 2018
Clinical pharmacology of intravitreal anti-VEGF drugsStefano Fogli, Marzia Del Re, Eleonora Rofi, et al.
Cancer Treatment Reviews|April 30, 2026
Streptozotocin revisited: Pharmacological determinants supporting new scheduling strategies in neuroendocrine tumoursNicola Fazio, Francesca Spada, Lavinia Benini, et al.
Journal of Theoretical Biology|November 10, 2015
Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancerSheema Sameen, Roberto Barbuti, Paolo Milazzo, et al.
Pageof 18